Cargando…
Circulating biomarkers that predict incident dementia
Dementia is currently diagnosed based on clinical symptoms and signs, but significant brain damage has already occurred by the time a clinical diagnosis of dementia is made, and it is increasingly recognized that this may be too late for any effective intervention. It would therefore be of great pub...
Autores principales: | Weinstein, Galit, Seshadri, Sudha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056619/ https://www.ncbi.nlm.nih.gov/pubmed/25031629 http://dx.doi.org/10.1186/alzrt235 |
Ejemplares similares
-
Circulating IGFBP‐2: a novel biomarker for incident dementia
por: McGrath, Emer R., et al.
Publicado: (2019) -
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016) -
The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
por: Vered, Shiraz, et al.
Publicado: (2023) -
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019) -
Associations between social relationship measures, serum brain-derived neurotrophic factor, and risk of stroke and dementia
por: Salinas, Joel, et al.
Publicado: (2017)